Literature DB >> 8993503

The cell cycle effects of camptothecin.

Z Darzynkiewicz1, S Bruno, G Del Bino, F Traganos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8993503     DOI： 10.1111/j.1749-6632.1996.tb26379.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells.

Authors:  G Del Bino; Z Darzynkiewicz; C Degraef; R Mosselmans; D Fokan; P Galand
Journal:  Cell Prolif       Date:  1999-02       Impact factor: 6.831

2.  Effect of P-glycoprotein modulators on the pharmacokinetics of camptothecin using microdialysis.

Authors:  T H Tsai; C H Lee; P H Yeh
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

3.  A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.

Authors:  Yuangang Zu; Dan Wang; Xiuhua Zhao; Ru Jiang; Qi Zhang; Dongmei Zhao; Yong Li; Baishi Zu; Zhiqiang Sun
Journal:  Int J Mol Sci       Date:  2011-06-28       Impact factor: 5.923

4.  The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis.

Authors:  J Czuwara-Ladykowska; B Makiela; E A Smith; M Trojanowska; L Rudnicka
Journal:  Arthritis Res       Date:  2001-08-02

5.  10‑Hydroxycamptothecin induces apoptosis in human fibroblasts by regulating miRNA‑23b‑3p expression.

Authors:  Lingrong Zeng; Yu Sun; Xiaolei Li; Jingcheng Wang; Lianqi Yan
Journal:  Mol Med Rep       Date:  2019-02-01       Impact factor: 2.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.